SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 111.97   2.18 (+1.99%) Volume: 232.45k 4:00 PM EDT 8-Jul-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities103/24/2004
4Statement of changes in beneficial ownership of securities103/22/2004
8-KCurrent report pursuant to Section 13 or 15(d)203/22/2004
8-KCurrent report pursuant to Section 13 or 15(d)203/18/2004
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals503/12/2004
10-KAnnual report pursuant to Section 13 or 15(d)10703/12/2004
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals103/09/2004
8-KCurrent report pursuant to Section 13 or 15(d)203/03/2004
3Initial statement of beneficial ownership of securities102/26/2004
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/18/2004
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/18/2004
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/18/2004
SC 13GStatement of acquisition of beneficial ownership by individuals202/13/2004
POS AMPost-Effective amendments for registration statement302/12/2004
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/12/2004
96979899100101102103104105106107108109110